Which pancreatitis patients would benefit from total pancreatectomy with islet autotransplantation? скачать в хорошем качестве

Which pancreatitis patients would benefit from total pancreatectomy with islet autotransplantation?

Chronic pancreatitis can cause unrelenting pain that disrupts daily life and often requires the long-term use of narcotics. For some, surgical intervention offers relief, but which surgery is right for each patient, and who needs the most advanced options? In a new episode of Dr. AI, pancreatic and hepatobiliary surgeon and Director of the Autologous Islet Cell Transplantation Program, Beth Schrope, MD, PhD, FACS, challenges ChatGPT to answer this rather complex question: Which patients with pancreatitis would benefit most from "total pancreatectomy with islet autotransplantation" (TPIAT)? Total pancreatectomy with autologous islet transplantation (TPIAT) is a highly specialized procedure for chronic pancreatitis. It involves removing the entire pancreas to relieve pain while transplanting the patient’s own insulin-producing islet cells into the liver. There, these cells can potentially produce insulin, helping avoid the otherwise inevitable diabetes that would follow the removal of the pancreas. While TPIAT can be life-changing, it’s not the right option for everyone. Dr. Schrope emphasizes the importance of individualized care: “We don’t have to take everybody’s pancreas out because they have chronic pain. There may be less extensive surgical options—like removing only part of the pancreas or bypassing a blocked duct (called a Puestow procedure)—that can effectively relieve symptoms.” So, where did the AI get it right, and where did it fall short? Watch to find out.